Cantourage Group SE: Leadership Transition Amidst Expansion

Cantourage Group SE is preparing for a leadership transition as CEO Philip Schetter plans to step down for personal reasons. Schetter will continue to lead until a successor is found, ensuring a smooth handover. Monique Jaqqam will remain as CFO, maintaining continuity in the company's financial management. Despite the leadership change, no strategic shifts are anticipated.

The Supervisory Board's mention of a 'new phase of development' suggests potential for a successor with extensive pharma experience. This aligns with Cantourage's launch of new cannabis active ingredients for pharmacy use, broadening their product range beyond flower-based formats.

First Berlin Equity Research reaffirms its BUY rating, with a target price of €11, indicating a 102% upside potential.